CIK 0001159036 · Large accelerated filer
HALOZYME THERAPEUTICS, INC.
Sign in to watch- Ticker
- HALO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880488686
- Phone
- (858) 794-8889
- Business address
- 12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
- Former names
- HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $19,884,955
- in 5 filings, $19.9M under 10b5-1 plans
Net −$19,884,955. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-09 | Torley Helen PRESIDENT AND CEO | Option exercise · Option to Purchase Common Stock 10b5-1 | −20,000 | $18.41 | $368K | 121,552 |
| 2026-09-01 | Appelhans Dannielle Director | Grant or award | +1,161 | 1,161 | ||
| 2026-09-01 | Appelhans Dannielle Director | Grant or award · Option to Purchase Common Stock | +1,778 | 1,778 | ||
| 2026-08-19 | Torley Helen PRESIDENT AND CEO | Option exercise 10b5-1 | +20,000 | $18.41 | $368K | 787,780 |
| 2026-08-19 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −7,200 | $106.36 | $766K | 780,580 |
| 2026-08-19 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −9,600 | $107.22 | $1.0M | 770,980 |
| 2026-08-19 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −3,200 | $107.77 | $345K | 767,780 |
| 2026-08-19 | Torley Helen PRESIDENT AND CEO | Option exercise · Option to Purchase Common Stock 10b5-1 | −20,000 | $18.41 | $368K | 141,552 |
| 2026-08-18 | Torley Helen PRESIDENT AND CEO | Option exercise 10b5-1 | +20,000 | $18.41 | $368K | 787,780 |
| 2026-08-18 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −5,703 | $103.08 | $588K | 782,077 |
| 2026-08-18 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −4,897 | $104.11 | $510K | 777,180 |
| 2026-08-18 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −9,400 | $104.87 | $986K | 767,780 |
| 2026-08-18 | Torley Helen PRESIDENT AND CEO | Option exercise · Option to Purchase Common Stock 10b5-1 | −20,000 | $18.41 | $368K | 161,552 |
| 2026-08-17 | Torley Helen PRESIDENT AND CEO | Option exercise 10b5-1 | +20,000 | $18.41 | $368K | 787,780 |
| 2026-08-17 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −900 | $98.96 | $89K | 786,880 |
| 2026-08-17 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −500 | $100.46 | $50K | 786,380 |
| 2026-08-17 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −2,100 | $101.77 | $214K | 784,280 |
| 2026-08-17 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −9,000 | $102.55 | $923K | 775,280 |
| 2026-08-17 | Torley Helen PRESIDENT AND CEO | Sale 10b5-1 | −7,500 | $103.48 | $776K | 767,780 |
| 2026-08-17 | Torley Helen PRESIDENT AND CEO | Option exercise · Option to Purchase Common Stock 10b5-1 | −20,000 | $18.41 | $368K | 181,552 |
Page 3 of 26 · 513 trades